Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression
about
Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesFXR signaling in the enterohepatic systemPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesGender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.Helicobacter hepaticus infection promotes hepatitis and preneoplastic foci in farnesoid X receptor (FXR) deficient mice.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.Bile acid signaling and liver regeneration.MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor.Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinomaUpregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.FXR and liver carcinogenesisDeletion of IFNγ enhances hepatocarcinogenesis in FXR knockout miceBile Acid Receptors and Liver Cancer.Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1.Bile acids activate YAP to promote liver carcinogenesis.Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapyMouse models for liver cancer.Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.CAMK2γ antagonizes mTORC1 activation during hepatocarcinogenesis.Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.The Hippo pathway in intestinal regeneration and disease.The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathwayThe FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma.Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3/SMAD3 pathway.Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse modelsFXR, intestinal FiXeR of hepatocellular carcinoma?Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation
P2860
Q26772317-126CABAD-26FF-4A2D-9BF6-CF1E4C7EA80DQ27014753-AB71CDB1-DCC1-4EAF-BEF3-79E11E374237Q28272678-D0D049DA-58BA-4307-8896-4A6387775426Q33687018-123AAFD0-5119-4289-B222-F9849BC215A9Q34128885-C9D22F2A-334F-4AA7-8411-3C38498CED04Q34425909-752198EF-4560-4203-85B1-C0FDDBDE6BC2Q34440796-F3FF6422-23C0-4882-95AA-4F8D38AA2828Q34580008-36676363-C15A-4B5F-BA86-B3362DE025B2Q35173008-95DB9C82-7CEF-4D25-8356-388619734460Q35551981-EA6BA29F-8447-46EB-8B88-DA2053FE6CE5Q35990400-ED065D67-C2E4-4944-9F03-C1FFC2F63D67Q36063712-3FA07914-E731-4284-B06A-9EC12306F019Q36335764-B1849F4F-7ECA-4C28-BC18-DB70C39C57D3Q36607910-41C89A29-92DC-4811-B3F3-11E406543ABDQ37448273-FD1BC263-A599-4F80-94D0-765517BEB478Q37651886-956EC1C0-4E1C-4B5E-8664-68C940B6D315Q37702183-79EF07DC-C295-4BE6-AC1C-6CF817CED05CQ38083387-FF10E845-3B37-4329-8B23-1376F095176DQ38572366-30C3847C-F0B3-48CE-B5DC-C813E3D52D8BQ38677715-466B75ED-FCAC-493B-954B-F51F14757A9BQ38732561-9D0A2A66-9C5D-4B42-BDA6-B9810865E6DDQ38782445-2230344F-59BF-4E1B-A2E4-88BDE08CFC3BQ38826172-A5E66302-852A-413E-9E79-EF25BC31F03EQ38943288-E3B670EC-C7D5-4673-B58B-343B2EED3F64Q39293774-679032BF-D8D6-44BD-AAA6-CF54C122B68EQ42053662-4AF4BF21-CE68-4F98-95DF-BF91E835A5E5Q42697966-FA2EBD56-E963-4363-BD5F-4DE3904A4340Q44968916-D3A25CC5-1402-48F0-81DE-BA78E35C22C6Q46309148-A5BAEEDD-0FDB-4BAD-AB66-6F248F76EF3CQ47217714-7B13B127-F9AE-48CF-9111-4060E0F77AD3Q48921020-274A9A85-9408-4AED-A11F-121B1ECFB472Q55255643-0AD6B529-0792-4D83-A48F-F98E258704E1Q57115983-CB4A04EA-61C6-4E57-A8E9-73B36BE93D81Q57147758-3A498253-91B4-4CFE-829E-B2F0C8EF79CDQ57147768-0CFE140D-1B35-4771-A732-078DE30554FA
P2860
Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@ast
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@en
type
label
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@ast
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@en
prefLabel
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@ast
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@en
P2093
P2860
P356
P1476
Hepatocarcinogenesis in FXR-/- ...... α regulation of FXR expression
@en
P2093
Barry M Forman
Lisheng Zhang
Rongzhen Xu
Weiping Zhou
Wendong Huang
Xiaoqiong Wang
Xiyong Liu
P2860
P304
P356
10.1210/ME.2011-1383
P577
2012-04-02T00:00:00Z